Sepsis Management and Patient Outcome Optimization in Critical Care

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection and remains one of the foremost challenges in critical care worldwide. Early recognition and prompt intervention are pivotal to interrupt the cascade of inflammation, endothelial injury and microcirculatory failure that drives organ dysfunction. Current management rests on timely administration of broad-spectrum antimicrobials, haemodynamic stabilisation through fluid resuscitation and vasopressors, and rapid source control of infection. Protocolised care bundles, incorporating early goal-directed therapy, have standardised practice and significantly reduced mortality where adherence is high. Beyond initial resuscitation, patient outcome optimisation increasingly relies on individualised monitoring of cardiac output, microvascular flow and biomarker-guided risk stratification. Immunomodulatory approaches are under investigation to rebalance host defence without exacerbating tissue injury. Special populations, notably the elderly and those with comorbidities, require tailored strategies that consider frailty, immunosenescence and the risk–benefit profile of invasive interventions. Advances in precision diagnostics and point-of-care testing promise to refine antimicrobial stewardship and inform dynamic adjustments to therapy. Global collaborative initiatives continue to address disparities in resource availability and reinforce training, quality improvement and system-level readiness to manage sepsis effectively.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Sepsis Management and Patient Outcome Optimization in Critical Care publication trend

The graph below shows the total number of articles in sepsis management and patient outcome optimization in critical care across all publications each year (not limited to Nature Index journals).

Technical terms

Sepsis: A life-threatening syndrome of organ dysfunction caused by a dysregulated host response to infection.

Septic shock: A subset of sepsis characterised by profound circulatory and metabolic abnormalities with higher risk of mortality.

Early goal-directed therapy (EGDT): A structured approach to achieve predefined haemodynamic targets within the initial hours of sepsis management.

Sepsis bundle: A set of time-bound, evidence-based interventions designed to standardise early care and improve outcomes.

MicroRNA (miRNA): Small non-coding RNA molecules that regulate gene expression post-transcriptionally and can modulate immune pathways.

Source control: The physical elimination of a focus of infection, for example via drainage or debridement, to halt ongoing contamination.

References

1. Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response. Journal of Clinical Investigation (2023).
2. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Critical Care (2019).
3. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Critical Care (2018).
4. Effect of Performance Improvement Programs on Compliance with Sepsis Bundles and Mortality: A Systematic Review and Meta-Analysis of Observational Studies. PLOS ONE (2015).
5. Sepsis and Immunosenescence in the Elderly Patient: A Review. Frontiers in Medicine (2017).